Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MN › EDEN PRAIRIE › GROUP HEALTH PLAN INC.

GROUP HEALTH PLAN INC.

NPI: 1215048913 · EDEN PRAIRIE, MN 55344 · Clinical Medical Laboratory · NPI assigned 08/31/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official BJORKMAN, LISA controls 18+ related entities in our dataset. Read more

$11.52M
Total Medicaid Paid
802,199
Total Claims
765,485
Beneficiaries
169
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBJORKMAN, LISA (DIRECTOR)
NPI Enumeration Date08/31/2006

Related Entities

Other providers sharing the same authorized official: BJORKMAN, LISA

ProviderCityStateTotal Paid
GROUP HEALTH PLAN, INC. MINNEAPOLIS MN $204.32M
GROUP HEALTH PLAN INC. MINNEAPOLIS MN $14.79M
GROUP HEALTH PLAN INC ANDOVER MN $12.93M
GROUP HEALTH PLAN INC SAINT PAUL MN $5.57M
GROUP HEALTH PLAN, INC STILLWATER MN $3.65M
GROUP HEALTH PLAN INC SAINT PAUL MN $3.61M
GROUP HEALTH PLAN INC SAINT PAUL MN $1.16M
PHYSICIANS NECK & BACK CLINICS ROSEVILLE MN $859K
GROUP HEALTH PLAN INC MINNEAPOLIS MN $828K
GROUP HEALTH PLAN, INC. SAINT PAUL MN $779K
GROUP HEALTH PLAN INC BLOOMINGTON MN $594K
LAKEVIEW MEMORIAL HOSPITAL ASSOCIATION INC STILLWATER MN $159K
GROUP HEALTH PLAN, INC. ANOKA MN $84K
GROUP HEALTH PLAN INC SOMERSET WI $80K
GROUP HEALTH PLAN INC HUDSON WI $53K
GROUP HEALTH PLAN, INC STILLWATER MN $50K
GROUP HEALTH PLAN, INC MAPLEWOOD MN $17K
GROUP HEALTH PLAN INC SAINT PAUL MN $1K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 144,808 $907K
2019 131,366 $1.71M
2020 89,582 $1.62M
2021 132,608 $2.70M
2022 94,440 $1.51M
2023 110,180 $1.40M
2024 99,215 $1.66M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 33,644 31,566 $2.31M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 24,306 23,349 $742K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 24,073 23,118 $736K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 24,972 23,384 $533K
86481 4,998 4,874 $467K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 21,221 20,829 $463K
84443 Thyroid stimulating hormone (TSH) 35,909 35,105 $408K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,343 7,007 $388K
83036 Hemoglobin; glycosylated (A1C) 53,696 52,761 $344K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 14,935 14,658 $318K
80061 Lipid panel 33,082 32,460 $272K
80048 Basic metabolic panel (calcium, ionized) 44,032 41,647 $220K
86780 17,498 17,216 $209K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 6,890 6,781 $209K
86803 12,477 12,236 $169K
80053 Comprehensive metabolic panel 20,064 19,417 $145K
82728 13,855 13,537 $143K
87340 11,800 11,554 $112K
82607 10,083 9,929 $108K
87086 Culture, bacterial; quantitative colony count, urine 18,253 17,310 $108K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,701 1,555 $105K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 5,448 5,364 $97K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1,489 1,414 $95K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,067 2,025 $91K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 581 573 $78K
84466 6,974 6,858 $72K
88142 4,366 4,289 $71K
86706 6,773 6,640 $71K
86480 1,425 1,391 $68K
83655 3,670 3,650 $68K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 13,836 13,000 $65K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1,990 1,899 $63K
87536 1,114 1,044 $63K
81513 444 437 $63K
86762 4,562 4,508 $62K
87481 1,908 1,823 $61K
84460 18,635 17,950 $59K
82570 17,572 16,554 $56K
86003 4,382 999 $55K
82565 18,661 17,694 $54K
86704 4,526 4,448 $52K
84702 3,604 2,442 $50K
85027 13,005 12,585 $50K
87088 7,759 7,506 $49K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 643 630 $49K
80076 10,808 10,377 $47K
82274 3,073 3,050 $47K
83970 2,076 2,031 $47K
82248 13,191 12,423 $45K
86787 3,359 3,335 $44K
82043 12,661 12,449 $44K
86850 5,146 5,022 $43K
84439 6,275 6,081 $42K
83540 8,652 8,498 $41K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,300 1,257 $41K
86708 3,120 3,074 $39K
84450 12,837 12,176 $38K
87077 6,113 5,505 $36K
86140 10,492 9,830 $36K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 3,242 3,222 $33K
87070 4,447 4,316 $32K
87338 2,591 2,560 $31K
83735 7,414 6,757 $31K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 236 236 $31K
86317 2,483 2,320 $30K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 2,235 2,206 $29K
87186 4,773 4,207 $28K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 158 152 $21K
82105 1,502 1,470 $21K
84146 1,355 1,284 $21K
87517 658 628 $20K
87209 1,152 647 $19K
83516 1,868 1,544 $19K
83001 1,201 1,176 $18K
84403 911 866 $17K
82784 1,865 1,540 $17K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 1,307 1,263 $15K
82247 3,875 2,807 $14K
84481 1,071 1,044 $13K
G0659 Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes 400 372 $13K
86900 4,731 4,623 $13K
86901 4,680 4,574 $13K
83718 1,947 1,922 $12K
84132 5,081 4,764 $12K
82950 2,843 2,789 $12K
82746 1,023 1,007 $11K
82670 516 491 $11K
82947 4,308 4,124 $11K
86360 350 312 $11K
80050 General health panel 219 212 $11K
83690 1,888 1,815 $10K
87177 1,441 804 $10K
83721 1,557 1,534 $10K
85652 6,034 5,791 $10K
83020 755 740 $9K
84270 632 596 $9K
83880 353 340 $9K
86359 348 310 $9K
84156 3,133 2,810 $9K
85018 4,799 4,681 $8K
85049 2,303 2,249 $8K
82465 2,299 2,272 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 201 137 $8K
82550 1,578 1,493 $7K
87480 575 558 $7K
87660 574 557 $7K
87510 574 557 $7K
86039 732 716 $7K
84295 2,804 2,716 $6K
86235 253 126 $6K
84153 575 562 $6K
84550 1,974 1,887 $6K
87081 1,879 1,820 $6K
87634 93 91 $6K
86160 724 358 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 403 382 $4K
84520 1,637 1,507 $4K
87205 1,143 1,088 $4K
80164 908 874 $4K
82951 304 300 $3K
82681 125 122 $3K
81001 1,345 1,265 $3K
80069 531 512 $3K
86038 381 377 $3K
87506 108 107 $3K
87522 Neg quan hep c or qual rna 98 98 $3K
85610 848 688 $3K
83002 156 156 $3K
86618 224 218 $3K
82310 799 773 $3K
86431 579 568 $2K
84100 838 753 $2K
86200 206 195 $2K
87631 16 15 $2K
86376 146 143 $2K
85730 298 241 $2K
87529 25 24 $1K
86225 171 158 $1K
84165 165 165 $1K
82040 355 350 $928.67
86696 53 50 $924.32
83520 188 186 $847.52
82627 39 39 $844.54
86147 25 14 $798.88
80178 192 178 $749.16
86765 46 46 $694.79
87563 26 25 $685.42
86695 52 49 $616.94
81025 100 94 $584.14
80177 74 69 $551.02
80074 13 13 $543.33
82533 46 44 $499.73
87493 30 28 $454.17
87147 233 211 $394.51
84155 167 166 $339.94
84075 125 106 $338.00
86341 24 18 $285.74
80051 75 73 $273.95
85045 66 66 $243.56
82150 59 54 $189.16
80175 29 29 $177.60
82785 12 12 $170.90
82952 67 66 $167.02
83993 12 12 $160.24
82610 14 12 $117.21
G0475 Hiv antigen/antibody, combination assay, screening 286 279 $50.00
87184 12 12 $40.89
X5622 365 311 $0.00
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 71 65 $0.00